参考文献/References:
[1] 刘香红.高通量血液透析对终末期肾病患者微炎性状态及细胞免疫的影响分析[J].中国医学工程,2021,29(1):93-96.
[2] 罗 楠,李新伦,陈凤锟,等.维持性血液透析相关肌肉减少症的患病率及危险因素的横断面调查[J].中国血液净化,2021,20(8):536-545.
[3] 舒亮辉,王星月,王 云,等.PDCA循环管理对基层医院维持性血液透析患者矿物质代谢及营养指标改善的疗效观察[J].中国血液净化,2021,20(5):351-355.
[4] 曹云松,丁昕宇,任 可.“养阴三法”治疗规律血液透析患者难治性高血压的经验浅谈[J].陕西中医,2015,36(3):336-338.
[5] 邓莉莉,廖晓辉,韩显文.高通量透析对尿毒症维持性血透患者的血脂及C-反应蛋白的分析研究[J].检验医学与临床,2015,12(11):1585-1586.
[6] 崔 俊,亢宁苏,周春霞,等.高通量血液透析联合百令胶囊对糖尿病肾病血液透析患者氧化应激、微炎性状态及生存质量的影响[J].疑难病杂志,2020,19(8):764-768.
[7] 宋家志,刘 婧,张丽涓,等.血液透析患者心血管标志物水平变化与其预后的相关性研究[J].内科急危重症杂志,2017,23(5):410-412.
[8] 王宇静,蔡 枫,李 兆,等.维持性血液透析患者缺铁状态与微炎症的相关性研究[J].中华医院感染学杂志,2016,26(2):372-373.
[9] 南 静.左卡尼汀联合阿托伐他汀钙对维持性血液透析患者微炎性反应状态的影响[J].中国医师进修杂志,2015,38(4):298-300.
[10] 刘绍芳,李金香,陈海燕,等.不同透析方式对MHD患者尿毒症毒素清除、炎症因子和氧化应激状态的影响[J].分子诊断与治疗杂志,2021,13(10):1656-1659.
[11] 张 媛,朱小静.维持性血液透析患者骨硬化蛋白、Klotho蛋白水平变化及与冠状动脉钙化相关性分析[J].陕西医学杂志,2021,50(10):1246-1249.
[12] 朱智峰.血液灌流+血液透析对长期血液透析患者免疫功能、Ca及P代谢的影响[J].世界最新医学信息文摘,2019,19(42):138-141.
[13] 郝 静,夏京华.加味桃红四物汤联合左卡尼汀对维持性血液透析患者营养状况的影响[J].陕西中医,2021,42(7):903-906.
[14] 王佳莹,谭 峰,吴宸极,等.维持性血液透析伴继发性甲状旁腺功能亢进患者甲状旁腺切除术后骨饥饿综合征发生影响因素及血清离子变化特征[J].陕西医学杂志,2021,50(3):334-337.
[15] Vasiljevski ER,Burns J,Bray P,et al.L-carnitine supplementation for muscle weakness and fatigue in children with neurofibromatosis type 1:A phase 2a clinical trial[J].American Journal of Medical Genetics,2021,185(10):2976-2985.
[16] Mansour H,Shereen M,Ibrahim AB,et al.Effect of L-carnitine on cardiotoxicity and apoptosis induced by imatinib through PDGF/PPARγ/MAPK pathways[J].Archives of Biochemistry and Biophysics,2021,704:108866.
[17] Wang DD,Mao YZ,He SM,et al.Quantitative efficacy of L-carnitine supplementation on glycemic control in type 2 diabetes mellitus patients[J].Expert Review of Clinical Pharmacology,2021,14(7):1-8.
[18] Baghban F,Hosseinzadeh F,Mozaffari KH,et al.The effect of L-carnitine supplementation on clinical symptoms,C-reactive protein and malondialdehyde in obese women with knee osteoarthritis:A double blind randomized controlled trial[J].BMC Musculoskeletal Disorders,2021,22(1):195.
[19] 徐 维,袁立英,喻海燕.前列地尔联合肾康注射液对维持性血液透析老年患者微炎症状态的影响[J].中国老年学杂志,2021,41(19):4308-4311.
[20] Yan Z,Chao X,Ou JH,et al.Effect of l-carnitine supplementation on renal anemia in patients on hemodialysis:A meta-analysis[J].International Urology and Nephrology,2021,53(10):1-8.
[21] Sugiyama M,Hazama T,Nakano K,et al.Effects of reducing L-carnitine supplementation on carnitine kinetics and cardiac function in hemodialysis patients:A multicenter,single-blind,placebo-controlled,randomized clinical trial[J].Nutrients,2021,13(6):1900.